Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07215585 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

Study acronym: SOUNDTRACK-D2
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 68 → 82 locations Completion date: Jul 28, 2033 to Jul 29, 2033 · Eligibility criteria expanded, about 14 words · Secondary endpoints: details revised at 2 of 16 entries Show 3 more changesShow less
    • Completion date: Jul 28, 2033 to Jul 29, 2033
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 2 of 16 entries
  2. Trial sites expanded: 64 → 68 locationsv8
  3. Study sites: 62 to 64v7
  4. Trial sites expanded: 45 → 62 locationsv6
  5. Study sites: 40 to 45 Primary completion date: Jul 9, 2030 to Jun 10, 2030v5 Show 1 more changeShow less
    • Primary completion date: Jul 9, 2030 to Jun 10, 2030
Show 3 earlier versionsHide 3 earlier versions
  1. Site details revised at 6 of 40 sitesv4
  2. Study sites: 39 to 40 Primary completion date: Jun 27, 2030 to Jul 9, 2030v3 Show 1 more changeShow less
    • Primary completion date: Jun 27, 2030 to Jul 9, 2030
  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 24 to 39 · Primary completion date: Jun 28, 2030 to Jun 27, 2030 · Completion date: Jul 29, 2033 to Jul 28, 2033 · 1 morev2 Show 4 more changesShow less
    • Study sites: 24 to 39
    • Primary completion date: Jun 28, 2030 to Jun 27, 2030
    • Completion date: Jul 29, 2033 to Jul 28, 2033
    • Start date changed from estimate of Nov 2, 2025 to Nov 11, 2025
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AstraZeneca
727 trials monitored
See 61 trials at risk
Non-Hodgkin Lymphoma
1,517 trials monitored
See 84 trials at risk
DLBCL
650 trials monitored
See 38 trials at risk
The purpose of this study is to measure the efficacy and safety of R-mini-CHOP × 2 followed by AZD0486 compared with R-mini-CHOP × 6 in elderly or unfit participants newly diagnosed with LBCL.
Trial Details
NCT Number NCT07215585
Lead Sponsor AstraZeneca
Conditions Large B-cell Lymphoma
Enrollment 420 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov